- Home
- ASTC vs ALZN Comparison
ASTC vs ALZN Comparison
Compare ASTC & ALZN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ASTC
- ALZN
- Stock Information
- Founded
- ASTC 1984
- ALZN 2016
- Country
- ASTC United States
- ALZN United States
- Employees
- ASTC N/A
- ALZN N/A
- Industry
- ASTC Biotechnology: Laboratory Analytical Instruments
- ALZN Medicinal Chemicals and Botanical Products
- Sector
- ASTC Industrials
- ALZN Health Care
- Exchange
- ASTC Nasdaq
- ALZN Nasdaq
- Market Cap
- ASTC 8.6M
- ALZN 7.5M
- IPO Year
- ASTC 1995
- ALZN 2021
- Fundamental
- Price
- ASTC $5.00
- ALZN $2.32
- Analyst Decision
- ASTC
- ALZN Strong Buy
- Analyst Count
- ASTC 0
- ALZN 1
- Target Price
- ASTC N/A
- ALZN $45.00
- AVG Volume (30 Days)
- ASTC 4.8K
- ALZN 71.9K
- Earning Date
- ASTC 05-13-2025
- ALZN 09-10-2025
- Dividend Yield
- ASTC N/A
- ALZN N/A
- EPS Growth
- ASTC N/A
- ALZN N/A
- EPS
- ASTC N/A
- ALZN N/A
- Revenue
- ASTC $903,000.00
- ALZN N/A
- Revenue This Year
- ASTC N/A
- ALZN N/A
- Revenue Next Year
- ASTC N/A
- ALZN N/A
- P/E Ratio
- ASTC N/A
- ALZN N/A
- Revenue Growth
- ASTC N/A
- ALZN N/A
- 52 Week Low
- ASTC $4.71
- ALZN $2.06
- 52 Week High
- ASTC $10.83
- ALZN $22.23
- Technical
- Relative Strength Index (RSI)
- ASTC 44.52
- ALZN 40.27
- Support Level
- ASTC $4.94
- ALZN $2.34
- Resistance Level
- ASTC $5.38
- ALZN $2.53
- Average True Range (ATR)
- ASTC 0.22
- ALZN 0.13
- MACD
- ASTC 0.02
- ALZN 0.02
- Stochastic Oscillator
- ASTC 38.16
- ALZN 29.03
About ASTC Astrotech Corporation (DE)
Astrotech Corp is a science and technology development company. The firm invents, acquires, and commercializes technological innovations sourced from internal research, universities, laboratories, and research institutions. The 1st Detect develops, manufactures, and sells chemical analyzers for use in the airport security, military, and breath analysis markets. AgLAB develops a series of mass spectrometers for use in the agriculture market.
About ALZN Alzamend Neuro Inc.
Alzamend Neuro Inc is an early clinical-stage biopharmaceutical company. It is focused on developing novel products for the treatment of neurodegenerative diseases and psychiatric disorders, including Alzheimer's. Its mission is to develop and market safe and effective treatments. The company's pipeline consists of two novel therapeutic drug candidates, AL001 - a patented ionic cocrystal technology delivering lithium via a therapeutic combination of lithium, proline and salicylate, and AL002 - a patented method using a mutant-peptide sensitized cell as a cell-based therapeutic vaccine that seeks to restore the ability of a patient's immunological system to combat Alzheimer's.